Canadian firm sees positive signs in COVID-19 vaccine trial, says courted to move production out of country

A Canadian drugmaker has posted promising Phase 1 trial results for its own COVID-19 vaccine, but is threatening to move its future trials and production out of the country if it doesn’t receive further support from the federal government.